Rupus Global is a leading brand in the distribution of medicines, tackling the issue of scarcity in hard-to-reach places. Our mission is to find and meet unmet needs, ensuring that healthcare is possible for all, regardless of their economic or geopolitical situation. We repackage goods to comply with local regulations, and our extensive distribution network spans across 70 countries, with a focus on the Middle East and North Africa.

As a B2B company, we strive to battle inequalities in access to medicine. We believe in dealing our cards with equality, reaching even the remotest locations and delivering medicines to all localities with limited access to drugs. Our commitment to excellence has been recognized with the prestigious Excellence award from the Institute of Economics Studies for Best Pharma Emerging Trading Company.

Since our establishment in 2014 as a direct limited company in Hong Kong, we have made remarkable progress. From trading pharmaceuticals in India to expanding our distribution network to 50 countries for our range of Pharmaceutical Intermediates, we have consistently grown. In 2016, we became a wholly owned subsidiary of Hong Kong Windson Exaim Limited.

We have also obtained patents for anticancer and Alzheimer drug intermediates and expanded into 20 African countries in 2019. Even during the pandemic in 2021, we have become a global supplier of lithium for pharmaceutical purposes. Our commitment to facing challenges head-on and growing is unwavering.

Contact us to learn more about our services and how we are making a positive impact in the world of medicine